Antigenics, Inc. (NASDAQ:AGEN)
CAPS Rating:
A biotechnology company, developing technologies and products to treat cancers and infectious diseases, based on immunological approaches.
Main Street 1; Wall Street 0
A biotechnology company, developing technologies and products to treat cancers and infectious diseases, based on immunological approaches.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
they just raised money at 51cents, so that should be a floor for a little while.